Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III – convergence toward clinical trials

Gut Pathogens

Eva M Selhub³  Alan C Logan²  Alison C Bested¹ 

[1] Complex Chronic Diseases Program, BC Women’s Hospital and Health Centre, B223A-4500 Oak Street, Vancouver, BC, V6H 3N1, Canada;CAMNR, 775 Blithedale Avenue Suite 364, Mill Valley, CA 94941, USA;Harvard Medical School and Massachusetts General Hospital, 40 Crescent St., Suite 201, Waltham, MA, 02453, USA

关键词: Microbial ecosystems;    MMP-9;    Intestinal permeability;    Diet;    Lipopolysaccharide endotoxin;    Microbial ecology;    Probiotics;    Anxiety;    Depression;    Autointoxication;    Intestinal microbiota;   

Others  :  821694
DOI  :  10.1186/1757-4749-5-4

 received in 2013-02-07, accepted in 2013-03-10,  发布年份 2013

【 摘 要 】

Rapid scientific and technological advances have allowed for a more detailed understanding of the relevance of intestinal microbiota, and the entire body-wide microbiome, to human health and well-being. Rodent studies have provided suggestive evidence that probiotics (e.g. lactobacillus and bifidobacteria) can influence behavior. More importantly, emerging clinical studies indicate that the administration of beneficial microbes, via supplementation and/or fecal microbial transplant (FMT), can influence end-points related to mood state (glycemic control, oxidative status, uremic toxins), brain function (functional magnetic resonance imaging fMRI), and mental outlook (depression, anxiety). However, despite the advances in the area of gastro-biological psychiatry, it becomes clear that there remains an urgent need to explore the value of beneficial microbes in controlled clinical investigations. With the history explored in this series, it is fair to ask if we are now on the cusp of major clinical breakthroughs, or are we merely in the quicksand of Autointoxication II?

【 授权许可】

   
2013 Bested et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Furney EE: Culture: A Modern Method. St. Louis, MO: Nixon Jones Printing Co; 1890.
• [2]The Editors, Anon: Dear Doctor. Ciba Symposium 1967, 15:106.
• [3]Cryan JF, O’Mahony SM: The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011, 23:187-192.
• [4]Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M: Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 2011, 25:397-407.
• [5]Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M: Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun 2010, 78:1509-1519.
• [6]Garber AK, Lustig RH: Is fast food addictive? Curr Drug Abuse Rev 2011, 4:146-162.
• [7]Brown K, DeCoffe D, Molcan E, Gibson DL: Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012, 4:1095-1119.
• [8]Goehler LE, Park SM, Opitz N, Lyte M, Gaykema RP: Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun 2008, 22:354-366.
• [9]Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, Lyte M: Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 2005, 19:334-344.
• [10]Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, Berger B, Huizinga JD, Kunze W, McLean PG, Bergonzelli GE, Collins SM, Verdu EF: The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011, 23:1132-1139.
• [11]Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF: Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011, 108:16050-16055.
• [12]Logan AC, Katzman M: Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses 2005, 64:533-538.
• [13]Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C: γ-Aminobutyric acid production by culturable bacteria from the human intestine. Appl Microbiol 2012, 113:411-417.
• [14]Abdou AM, Higashiguchi S, Horie K, Kim M, Hatta H, Yokogoshi H: Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors 2006, 26:201-208.
• [15]Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, Lu J, Khan WI, Corthesy-Theulaz I, Cherbut C, Bergonzelli GE, Collins SM: Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139:2102-2112.
• [16]Arnold L: Alterations in the endogenous enteric bacterial flora and microbic permeability of the intestinal wall in relation to the nutritional and meteorological changes. J Hygiene 1929, 29:82-116.
• [17]Sutherland J, Miles M, Hedderley D, Li J, Devoy S, Sutton K, Lauren D: In vitro effects of food extracts on selected probiotic and pathogenic bacteria. Int J Food Sci Nutr 2009, 60:717-727.
• [18]Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M: Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 2009, 96:557-567.
• [19]Lindeberg S: Paleolithic diets as a model for prevention and treatment of Western disease. Am J Hum Biol 2012, 24:110-115.
• [20]Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF, Collins SM: The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141:599-609.
• [21]Carvalho BM, Guadagnini D, Tsukumo DM, Schenka AA, Latuf-Filho P, Vassallo J, Dias JC, Kubota LT, Carvalheira JB, Saad MJ: Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 2012, 55:2823-2834.
• [22]Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, Tsuchie K, Taki M, Ishihara K, Araki T, Horiguchi J: Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 2012, 37:222-226.
• [23]Garrido-Mesa N, Utrilla P, Comalada M, Zorrilla P, Garrido-Mesa J, Zarzuelo A, Rodríguez-Cabezas ME, Gálvez J: The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. Biochem Pharmacol 2011, 82:1891-1900.
• [24]Rodrigues DM, Sousa AJ, Hawley SP, Vong L, Gareau MG, Kumar SA, Johnson-Henry KC, Sherman PM: Matrix metalloproteinase 9 contributes to gut microbe homeostasis in a model of infectious colitis. BMC Microbiol 2012, 12:105. BioMed Central Full Text
• [25]Mikami Y, Dobschütz EV, Sommer O, Wellner U, Unno M, Hopt U, Keck T: Matrix metalloproteinase-9 derived from polymorphonuclear neutrophils increases gut barrier dysfunction and bacterial translocation in rat severe acute pancreatitis. Surgery 2009, 145:147-156.
• [26]Munjal C, Tyagi N, Lominadze D, Tyagi SC: Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability. J Cell Biochem 2012, 113:1159-1169.
• [27]Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, Brittain C, Rujescu D, Giegling I, Turck CW, Holsboer F, Bullmore ET, Middleton L, Merlo-Pich E, Alexander RC, Muglia P: Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case–control collections. PLoS One 2010, 5:e9166.
• [28]Rybakowski JK, Remlinger-Molenda A, Czech-Kucharska A, Wojcicka M, Michalak M, Losy J: Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression. J Affect Disord 2013, 146:286-289.
• [29]Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, Shiina A, Hashimoto T, Kanahara N, Hasegawa T, Enohara M, Kimura A, Iyo M, Hashimoto K: Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One 2012, 7:e42676.
• [30]Scoditti E, Calabriso N, Massaro M, Pellegrino M, Storelli C, Martines G, De Caterina R, Carluccio MA: Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch Biochem Biophys 2012, 527:81-89.
• [31]Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R: Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. Nutr 2009, 139:905-911.
• [32]Kamiya T, Wang L, Forsythe P, Goettsche G, Mao Y, Wang Y, Tougas G, Bienenstock J: Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague–Dawley rats. Gut 2006, 55:191-196.
• [33]McKernan DP, Fitzgerald P, Dinan TG, Cryan JF: The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 2010, 22:1029-1035.
• [34]Johnson AC, Greenwood-Van MB, McRorie J: Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat. Dig Dis Sci 2011, 56:3179-3186.
• [35]Agostini S, Goubern M, Tondereau V, Salvador-Cartier C, Bezirard V, Lévèque M, Keränen H, Theodorou V, Bourdu-Naturel S, Goupil-Feuillerat N, Legrain-Raspaud S, Eutamene H: A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol Motil 2012, 24:376-e172.
• [36]Ait-Belgnaoui A, Eutamene H, Houdeau E, Bueno L, Fioramonti J, Theodorou V: Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats. Neurogastroenterol Motil 2009, 21:567-573.
• [37]Verdú EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F, Collins SM: Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006, 55:182-190.
• [38]Alvarez WC: Origin of the so-called autointoxication symptoms. JAMA 1919, 72:8-13.
• [39]Stevens S, Gerlach AL, Cludius B, Silkens A, Craske MG, Hermann C: Heartbeat perception in social anxiety before and during speech anticipation. Behav Res Ther 2011, 49:138-143.
• [40]Stasi C, Rosselli M, Bellini M, Laffi G, Milani S: Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol 2012, 47:1177-1185.
• [41]Furnari M, Savarino E, Bruzzone L, Moscatelli A, Gemignani L, Giannini EG, Zentilin P, Dulbecco P, Savarino V: Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis 2012, 2:157-163.
• [42]Basseri RJ, Basseri B, Pimentel M, Chong K, Youdim A, Low K, Hwang L, Soffer E, Chang C, Mathur R: Intestinal methane production in obese individuals is associated with a higher body mass index. Gastroenterol Hepatol 2012, 8:22-28.
• [43]Holma R, Korpela R, Sairanen U, Blom M, Rautio M, Poussa T, Saxelin M, Osterlund P: Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-Fluorouracil chemotherapy for colorectal cancer. J Clin Gastroenterol 2013, 47:45-51.
• [44]Pimentel M, Chang C: Inflammation and microflora. Gastroenterol Clin North Am 2011, 40:69-85.
• [45]Leiby A, Mehta D, Gopalareddy V, Jackson-Walker S, Horvath K: Bacterial overgrowth and methane production in children with encopresis. J Pediatr 2010, 156:766-770.
• [46]Cayan S, Doruk E, Bozlu M, Duce MN, Ulusoy E, Akbay E: The assessment of constipation in monosymptomatic primary nocturnal enuresis. Int Urol Nephrol 2001, 33:513-516.
• [47]Otu-Bassey IB, Ejezie GC, Epoke J, Useh MF: Enterobiasis and its relationship with anal itching and enuresis among school-age children in Calabar, Nigeria. Ann Trop Med Parasitol 2005, 99:611-616.
• [48]Persico AM, Napolioni V: Urinary p-cresol in autism spectrum disorder. Neurotoxicol Teratol 2012. In Press
• [49]Chen GG, Fiori LM, Moquin L, Gratton A, Mamer O, Mechawar N, Turecki G: Evidence of altered polyamine concentrations in cerebral cortex of suicide completers. Neuropsychopharmacology 2010, 35:1477-1484.
• [50]Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, Baca-Garcia E: New perspectives in glutamate and anxiety. Pharmacol Biochem Behav 2012, 100:752-774.
• [51]Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, Lin MY, Chen HC: Association of symptoms of depression with progression of CKD. Am J Kidney Dis 2012, 60:54-61.
• [52]Davey A, Elias MF, Robbins MA, Seliger SL, Dore GA: Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant 2012. In Press
• [53]Wang CP, Lu LF, Yu TH, Hung WC, Chiu CA, Chung FM, Yeh LR, Chen HJ, Lee YJ, Houng JY: Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure. Atherosclerosis 2010, 211:579-583.
• [54]Massy ZA, Barreto DV, Barreto FC, Vanholder R: Uraemic toxins for consideration by the cardiologist-Beyond traditional and non-traditional cardiovascular risk factors. Atherosclerosis 2010, 211:381-383.
• [55]Pedreañez A, Arcaya JL, Carrizo E, Rincón J, Viera N, Peña C, Vargas R, Mosquera J: Experimental depression induces renal oxidative stress in rats. Physiol Behav 2011, 104:1002-1009.
• [56]Tsurugano S, Nakao M, Takeuchi T, Nomura K, Yano E: Job stress strengthens the link between metabolic risk factors and renal dysfunction in adult men. Tohoku J Exp Med 2012, 226:101-108.
• [57]Niwa T: Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr 2010, 20(5 Suppl):S2-S6.
• [58]Hsu HJ, Yen CH, Chen CK, Wu IW, Lee CC, Sun CY, Chang SJ, Chou CC, Hsieh MF, Chen CY, Hsu CY, Tsai CJ, Wu MS: Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis. Gen Hosp Psychiatry 2012. In Press
• [59]Sandler M, Przyborowska A, Halket J, Watkins P, Glover V, Coates ME: Urinary but not brain isatin levels are reduced in germ-free rats. J Neurochem 1991, 57:1074-1075.
• [60]Medvedev A, Igosheva N, Crumeyrolle-Arias M, Glover V: Isatin: role in stress and anxiety. Stress 2005, 8:175-183.
• [61]Singh B, Kumar P, Nagpaul JP, Sharma R, Bansal RC: Effect of administration of isatin on alkaline phosphatase of various organs of rat. Indian J Physiol Pharmacol 1978, 22:297-300.
• [62]Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW: Colonic contribution to uremic solutes. J Am Soc Nephrol 2011, 22:1769-1776.
• [63]Vanholder R, Bammens B, De Loor H, Glorieux G, Meijers B, Schepers E, Massy Z, Evenepoel P: Warning: the unfortunate end of p-cresol as a uraemic toxin. Nephrol Dial Transplant 2011, 26:1464-1467.
• [64]Goo YA, Cain K, Jarrett M, Smith L, Voss J, Tolentino E, Tsuji J, Tsai YS, Panchaud A, Goodlett DR, Shulman RJ, Heitkemper M: Urinary Proteome Analysis of Irritable Bowel Syndrome (IBS) Symptom Subgroups. J Proteome Res 2012, 11:5650-5662.
• [65]Patel KP, Luo FJ, Plummer NS, Hostetter TH, Meyer TW: The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 2012, 7:982-988.
• [66]Meyer TW, Hostetter TH: Uremic solutes from colon microbes. Kidney Int 2012, 81:949-954.
• [67]Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdeau E, Fioramonti J, Bueno L, Theodorou V: Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 2012, 37:1885-1895.
• [68]Wang Y, Kirpich I, Liu Y, Ma Z, Barve S, McClain CJ, Feng W: Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol 2011, 179:2866-2875.
• [69]Wang Y, Li Y, Xie J, Zhang Y, Wang J, Sun X, Zhang H: Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol 2012, 15:30-37.
• [70]Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG: The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008, 43:164-174.
• [71]Komatsuzaki N, Shima J: Effects of live Lactobacillus paracasei on plasma lipid concentration in rats fed an ethanol-containing diet. Biosci Biotechnol Biochem 2012, 76:232-237.
• [72]Wall R, Marques TM, O’Sullivan O, Ross RP, Shanahan F, Quigley EM, Dinan TG, Kiely B, Fitzgerald GF, Cotter PD, Fouhy F, Stanton C: Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr 2012, 95:1278-1287.
• [73]Girard SA, Bah TM, Kaloustian S, Lada-Moldovan L, Rondeau I, Tompkins TA: Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr 2009, 102:1420-1425.
• [74]Jung IH, Jung MA, Kim EJ, Han MJ, Kim DH: Lactobacillus pentosus var. plantarum C29 protects scopolamine-induced memory deficit in mice. J Appl Microbiol 2012, 113:1498-1506.
• [75]Tikhonova M, Kulikov AV: Antidepressant-Like Effects of Central BDNF Administration in Mice of Antidepressant Sensitive Catalepsy (ASC) Strain. Chin J Physiol 2012, 55:284-293.
• [76]Eutamene H, Bueno L: Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut 2007, 56:1495-1497.
• [77]Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG: Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010, 170:1179-1188.
• [78]Singh PK, Chopra K, Kuhad A, Kaur IP: Role of Lactobacillus acidophilus loaded floating beads in chronic fatigue syndrome: behavioral and biochemical evidences. Neurogastroenterol Motil 2012, 24:366-e170.
• [79]Shen Q, Shang N, Pinglan L: In vitro and in vivo antioxidant activity of Bifidobacterium animalis 01 isolated from centenarians. Curr MicrobiolIn Press
• [80]Collins S, Verdu E, Denou E, Bercik P: The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome. Dig Dis 2009, 27(Suppl 1):85-89.
• [81]Herpfer I, Katzev M, Feige B, Fiebich BL, Voderholzer U, Lieb K: Effects of substance P on memory and mood in healthy male subjects. Hum Psychopharmacol 2007, 22:567-573.
• [82]Lieb K, Walden J, Grunze H, Fiebich BL, Berger M, Normann C: Serum levels of substance P and response to antidepressant pharmacotherapy. Pharmacopsychiatry 2004, 37:238-239.
• [83]Pertwee RG: Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci 2012, 367:3353-3363.
• [84]Elliott MB, Tuma RF, Amenta PS, Barbe MF, Jallo JI: Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury. J Neurotrauma 2011, 28:973-981.
• [85]Ramirez SH, Haskó J, Skuba A, Fan S, Dykstra H, McCormick R, Reichenbach N, Krizbai I, Mahadevan A, Zhang M, Tuma R, Son YJ, Persidsky Y: Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood–brain barrier dysfunction under inflammatory conditions. J Neurosci 2012, 32:4004-4016.
• [86]Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel JF, Ardid D, Desreumaux P: Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007, 13:35-37.
• [87]Bernardo D, Sánchez B, Al-Hassi HO, Mann ER, Urdaci MC, Knight SC, Margolles A: Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide. PLoS One 2012, 7:e36262.
• [88]Campana R, Federici S, Ciandrini E, Baffone W: Antagonistic activity of Lactobacillus acidophilus ATCC 4356 on the growth and adhesion/invasion characteristics of human Campylobacter jejuni. Curr Microbiol 2012, 64:371-378.
• [89]Prescott SL: Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases. J Allergy Clin Immunol 2013, 131:23-30.
• [90]Barouei J, Moussavi M, Hodgson DM: Effect of maternal probiotic intervention on HPA axis, immunity and gut microbiota in a rat model of irritable bowel syndrome. PLoS One 2012, 7:e46051.
• [91]Turck FB: Intestinal venous stasis. NY Med J 1916, 104:1072-1073.
• [92]Turck FB: The mechanism of intestinal atony in children – etiology and treatment. NY State J Med 1918, 18:1-6.
• [93]Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermúdez-Humarán LG, Smirnova N, Bergé M, Sulpice T, Lahtinen S, Ouwehand A, Langella P, Rautonen N, Sansonetti PJ, Burcelin R: Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011, 3:559-572.
• [94]Rook GA, Raison CL, Lowry CA: Can we vaccinate against depression? Drug Discov Today 2012, 17:451-458.
• [95]O’Brien ME, Anderson H, Kaukel E, O’Byrne K, Pawlicki M, Von Pawel J: SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann Oncol 2004, 15:906-914.
• [96]Satterlee GR, Eldridge WW: Symptomatology of the nervous system in chronic intestinal toxemia. JAMA 1917, 69:1414-1418.
• [97]Heinemann PG, Hefferan M: A study of Bacillus Bulgaricus. J Infect Dis 1909, 6:304-318.
• [98]Teixeira LC, Peixoto RS, Cury JC, Sul WJ, Pellizari VH, Tiedje J, Rosado AS: Bacterial diversity in rhizosphere soil from Antarctic vascular plants of Admiralty Bay, maritime Antarctica. ISME J 2010, 4:989-1001.
• [99]Matthews DM, Jenks SM: Effect of Mycobacterium vaccae on learning in mice. San Diego, California: Poster 641; 2010. [Proceedings of the American Society for Microbiology 110th General Meeting]
• [100]Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V: Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012, 28:539-543.
• [101]Martarelli D, Verdenelli MC, Scuri S, Cocchioni M, Silvi S, Cecchini C, Pompei P: Effect of a probiotic intake on oxidant and antioxidant parameters in plasma of athletes during intense exercise training. Curr Microbiol 2011, 62:1689-1696.
• [102]Penckofer S, Quinn L, Byrn M, Ferrans C, Miller M, Strange P: Does glycemic variability impact mood and quality of life? Diabetes Technol Ther 2012, 14:303-310.
• [103]Soifer LO, Peralta D, Dima G, Besasso H: Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study. Acta Gastroenterol Latinoam 2010, 40:323-327.
• [104]Tillisch K, Labus JS, Ebrat B, Stains J, Naliboff B, Guyonnet D, Legrain-Raspaud S, Trotin B, Mayer EA: Modulation of the brain-gut axis after 4-week intervention with a probiotic fermented dairy product. Gastroenterology 2012, 142(Suppl 1):S-115.
• [105]Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, De Vos WM, Hoekstra JB, Nieuwdorp M: Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143:913-916. e7
• [106]Borody T, Leis S, Campbell J, Torres M, Nowak A: Fecal microbiota transplantation (FMT) in multiple sclerosis (MS). Am J Gastroenterol 2011, 106:S352.
• [107]Fei N, Zhao L: An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 2012. In Press
• [108]Oliva S, Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G, Cucchiara S, Stronati L: Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 2012, 35:327-334.
• [109]Audy EO, Claud EC, Gloor GB, Allen-Vercoe E: Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes 2012, 1:1-13.
• [110]Bercik P, Collins SM, Verdu EF: Microbes and the gut-brain axis. Neurogastroenterol Motil 2012, 24:405-413.
• [111]Benton D, Williams C, Brown A: Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2007, 61:355-361.
• [112]Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM: A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009, 1:6. BioMed Central Full Text
• [113]Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A: Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011, 105:755-764.
• [114]Messaoudi M, Violle N, Bisson JF, Desor D, Javelot H, Rougeot C: Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011, 2:256-261.
• [115]Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR: Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009, 29:508-518.
• [116]Galdston I: On the futility of medical history. Can Med Assoc J 1965, 93:807-811.
• [117]Maes M, Twisk F: Chronic fatigue syndrome: Harvey and Wessely’s (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Med 2010, 8:35. BioMed Central Full Text
• [118]Wessely S: Surgery for the treatment of psychiatric illness: the need to test untested theories. J R Soc Med 2009, 102:445-451.
• [119]Tayama J, Nakaya N, Hamaguchi T, Tomiie T, Shinozaki M, Saigo T, Shirabe S, Fukudo S: Effects of personality traits on the manifestations of irritable bowel syndrome. Biopsychosoc Med 2012, 6:20. BioMed Central Full Text
• [120]Galdston I: The Roots of Psychosomatic Medicine. Can Med Assoc J 1954, 70:127-132.
• [121]Froberg-Fejko KM, Lecker JL: Going back to nature: the benefits of wood enrichment. Lab Anim 2012, 41:346-347.
• [122]Matsumoto M, Inoue R, Tsukahara T, Ushida K, Chiji H, Matsubara N, Hara H: Voluntary running exercise alters microbiota composition and increases n-butyrate concentration in the rat cecum. Biosci Biotechnol Biochem 2008, 72:572-576.
• [123]Medina S, Domínguez-Perles R, García-Viguera C, Cejuela-Anta R, Martínez-Sanz JM, Ferreres F, Gil-Izquierdo A: Physical activity increases the bioavailability of flavanones after dietary aronia-citrus juice intake in triathletes. Food Chem 2012, 135:2133-2137.
• [124]Maesako M, Uemura K, Kubota M, Kuzuya A, Sasaki K, Asada M, Watanabe K, Hayashida N, Ihara M, Ito H, Shimohama S, Kihara T, Kinoshita A: Environmental enrichment ameliorated high-fat diet-induced Aβ deposition and memory deficit in APP transgenic mice. Neurobiol Aging 2012, 33:1011. e11-23
• [125]Suzuki C, Kimoto-Nira H, Kobayashi M, Nomura M, Sasaki K, Mizumachi K: Immunomodulatory and cytotoxic effects of various Lactococcus strains on the murine macrophage cell line J774.1. Int J Food Microbiol 2008, 123:159-165.
• [126]Di Cagno R, Minervini G, Sgarbi E, Lazzi C, Bernini V, Neviani E, Gobbetti M: Comparison of phenotypic (Biolog System) and genotypic (random amplified polymorphic DNA-polymerase chain reaction, RAPD-PCR, and amplified fragment length polymorphism, AFLP) methods for typing Lactobacillus plantarum isolates from raw vegetables and fruits. Int J Food Microbiol 2010, 143:246-253.
• [127]Abou-Donia MB, El-Masry EM, Abdel-Rahman AA, McLendon RE, Schiffman SS: Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J Toxicol Environ Health A 2008, 71:1415-1429.
• [128]Mueller F: Yoghurt: The Bulgarian national dish, the anti-toxin for old age. Health Culture 1913, 19:295.
• [129]Wright C: Forget prozac, try probiotics. The Natural News 2012.
• [130]Specter M: Germs are us. The New Yorker 2012, 88(Oct 22):32-39.
• [131]Matsumoto M, Kurihara S, Kibe R, Ashida H, Benno Y: Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS One 2011, 6:e23652.
• [132]Altmaier E, Emeny RT, Krumsiek J, Lacruz ME, Lukaschek K, Häfner S, Kastenmüller G, Römisch-Margl W, Prehn C, Mohney RP, Evans AM, Milburn MV, Illig T, Adamski J, Theis F, Suhre K, Ladwig KH: Psychoneuroendocrinology. 2012. In Press